Argenx
ARGX
#534
Rank
ยฃ30.34 B
Marketcap
ยฃ496.30
Share price
-0.35%
Change (1 day)
77.78%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): -ยฃ53 Million

According to Argenx 's latest financial reports the company's current earnings are ยฃ1.85 Billion. In 2023 the company made an earning of -ยฃ0.25 Billion, an increase over its 2022 earnings that were of -ยฃ0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ53 Million-78.13%
2023 -ยฃ0.25 Billion-58.25%
2022 -ยฃ0.59 Billion
2019 -ยฃ0.16 Billion124.95%
2018 -ยฃ70.41 Million132.04%
2017 -ยฃ30.35 Million54.86%
2016 -ยฃ19.6 Million33%
2015 -ยฃ14.74 Million13.63%
2014 -ยฃ12.97 Million46.25%
2013 -ยฃ8.87 Million